Mirum Pharmaceuticals Inc. has agreed to acquire Bluejay Therapeutics, a privately held biotechnology company focused on ...

Quotient Sciences and Intrepid Labs have announced a multi-year strategic partnership to advance the use of artificial ...

Natera Inc., a cell-free DNA and precision medicine company, has acquired Foresight Diagnostics, a leader in ultrasensitive ...

Jubilant Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Daniel J. O'Connor as President & Chief ...

As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...

The FDA has approved BMS’ Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed CAR T cell therapy, for adults with ...

Vetter, a globally leading CDMO, announced the retirement of its Managing Director, Thomas Otto, after over 35 years at the ...

Add capabilities in Europe and the U.S. for enhanced third-party logistics to support specialty pharmaceuticals.

Neurimmune has expanded its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, an AstraZeneca company ...

BD said all configurations feature high-throughput automation and software designed for large dataset management and ...

Designed to improve analytical capabilities by separating particles prior to analysis, enabling high-resolution ...

Fresenius Kabi has introduced two new products in its Simplist portfolio of ready-to-administer prefilled syringes: Simplist ...